Evidence map›Paper›PMID 30867060›Full record

ArticleActa neuropathologica communications2019

HR23B pathology preferentially co-localizes with p62, pTDP-43 and poly-GA in C9ORF72-linked frontotemporal dementia and amyotrophic lateral sclerosis.

Frederike W Riemslagh, Hannes Lans, Harro Seelaar, Lies-Anne W F M Severijnen, Shamiram Melhem, Wim Vermeulen, Eleonora Aronica, R Jeroen Pasterkamp, John C van Swieten, Rob Willemsen

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeting GeneInternational journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Frederike W RiemslaghDepartment of Clinical Genetics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. f.w.riemslagh@erasmusmc.nl.ORCID 0000-0002-8530-3339
Hannes LansDepartment of Molecular Genetics, Oncode Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Harro SeelaarDepartment of Neurology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Lies-Anne W F M SeverijnenDepartment of Clinical Genetics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Shamiram MelhemDepartment of Neurology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Wim VermeulenDepartment of Molecular Genetics, Oncode Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Eleonora AronicaDepartment of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
R Jeroen PasterkampDepartment of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
John C van SwietenDepartment of Neurology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Rob WillemsenDepartment of Clinical Genetics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Erasmus MC · NLAmsterdam Neuroscience · NLUtrecht University · NL

Funding

ALS stichting (NL) 2014-28EU Joint Programme - Neurodegenerative Disease Research 733051042European Research Council 340988
6 · The paper itself

Abstract

Human homologue of yeast UV excision repair protein Rad23b (HR23B) inclusions are found in a number of neurodegenerative diseases, including frontotemporal dementia (FTD), Huntington's disease (HD), spinocerebellar ataxia type 3 and 7 (SCA3/7), fragile X associated tremor/ataxia syndrome (FXTAS) and Parkinson's disease (PD). Here, we describe HR23B pathology in C9ORF72 linked FTD and amyotrophic lateral sclerosis (ALS) cases. HR23B presented in neuropils, intranuclear inclusions and cytoplasmic and perinuclear inclusions and was predominantly found in cortices (frontal, temporal and motor), spinal cord and hippocampal dentate gyrus. HR23B co-localized with poly-GA-, pTDP-43- and p62-positive inclusions in frontal cortex and in hippocampal dentate gyrus, the latter showing higher co-localization percentages. HR23B binding partners XPC, 20S and ataxin-3, which are involved in nucleotide excision repair (NER) and the ubiquitin-proteasome system (UPS), did not show an aberrant distribution. However, C9ORF72 fibroblasts were more sensitive for UV-C damage than healthy control fibroblasts, even though all factors involved in NER localized normally to DNA damage and the efficiency of DNA repair was not reduced. HR23Bs other binding partner NGly1/PNGase, involved in ER-associated degradation (ERAD) of misfolded proteins, was not expressed in the majority of neurons in C9FTD/ALS brain sections compared to non-demented controls. Our results suggest a difference in HR23B aggregation and co-localization pattern with DPRs, pTDP-43 and p62 between different brain areas from C9FTD/ALS cases. We hypothesize that HR23B may play a role in C9ORF72 pathogenesis, possibly by aberrant ERAD functioning.

Indexed as

AgedAmyotrophic Lateral SclerosisC9orf72 ProteinDNA-Binding ProteinsDNA Repair EnzymesFemaleFrontotemporal DementiaHumansMaleMiddle AgedProtein AggregatesProteinsRNA-Binding ProteinsC9orf72 ProteinC9orf72 protein, humanDNA-Binding ProteinsDNA Repair EnzymesP62 protein, humanpoly(glycyl-alanyl)Protein AggregatesProteinsRAD23B protein, humanRNA-Binding ProteinsTARDBP protein, humanALSC9ORF72DPRsERADFTDHR23BNGly1Poly-GA

Identifiers

PMID30867060
PMCPMC6416930
OpenAlexW2943553206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.